Perspective Therapeutics Inc. (CATX) — Capital Reinvestment Ratio
Latest as of September 2024:
8.83x
Perspective Therapeutics Inc. (CATX) has a Capital Reinvestment Ratio of 8.83x as of September 2024, meaning it reinvests 9% of its operating cash flow ($3.37 Million) in capital expenditures ($29.71 Million). See Perspective Therapeutics Inc. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
8.83x
Capex / Operating Cash Flow
Operating Cash Flow
$3.37 Million
USD
Capital Expenditures
$29.71 Million
USD
Data as of
Sep 2024
Most recent filing
Perspective Therapeutics Inc. Capital Reinvestment Ratio (1999–2001)
This chart tracks Perspective Therapeutics Inc.'s Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Perspective Therapeutics Inc. (1999–2001)
Year-by-year Capital Reinvestment Ratio for Perspective Therapeutics Inc. from 1999 to 2001. For live market cap and broader valuation context, see CATX company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2001 | 0.13x | $365.34K | $48.81K | ▲ +0.0% |
| 2000 | 0.13x | $365.34K | $48.81K | ▼ -76.9% |
| 1999 | 0.58x | $275.97K | $159.58K | ▲ +0.0% |
| 1999 | 0.58x | $275.97K | $159.58K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow